An uncommon combination of theoretical depth and shop-floor practice.
Trained as a theoretical physicist at Cornell and a materials chemist at MIT, Dr. Currie has spent fifty years working at the interface where fundamental science becomes commercial technology — designing and manufacturing semiconductor heterostructures, thin-film coatings, microfluidic devices, electrochemical biosensors, and full FDA-pathway medical instruments. He has been a tenured Full Professor at three universities, the founding director of four research laboratories, the inventor or co-inventor of more than 19 patents, and a continuously practicing Professional Engineer in electrical engineering and engineering physics.
Today, as Chief Science Officer of Cambridge Medical Technologies, LLC and Professor Emeritus at Georgetown University, he advises medical-device companies, semiconductor groups, federal funders, and law firms on the topics where he has personally built, tested, published, and patented the underlying science.
Six domains, deeply earned.
Transdermal Biosensors & Interstitial-Fluid Analysis
Invention, design, fabrication, and clinical validation of non-invasive painless transdermal sampling and analysis devices for glucose, lactate, ethyl alcohol, bilirubin, cholesterol, melatonin, and troponin in interstitial fluid. Includes hydrogel electrochemistry, redox cofactor incorporation, ELISA-style on-electrode bioassays, and multi-analyte panels.
Thin-Film Semiconductor Devices & Photonics
Si MOS, polycrystalline and amorphous silicon, InP/InGaAs heterostructure insulated-gate FETs operating to 6 GHz, GaAs waveguide modulators, quantum-confined Stark-effect devices, and III-V scintillating radiation detectors. From band-alignment engineering to wafer-scale fabrication.
MEMS, Microfluidics & Electrochemical Microsensors
SU-8 multi-layer dermal patches, PDMS microfluidics, sputtered NASICON solid-electrolyte CO₂/NO₂/SO₂ sensors, screen-printed and evaporated-gold electrode arrays, bistable electrothermal CMOS actuators, and dry-release polymer structures for fluidic encapsulation.
FDA, ISO 13485 & Regulatory Strategy
Pathway selection between 510(k), De Novo, and PMA for novel non-invasive monitoring devices; QMS implementation; SOP authoring; design controls; risk management to ISO 14971; clinical-evaluation reports; and audit preparation, coordinated with regulatory consulting and contract manufacturing partners.
Federal Grant Strategy & Scientific Writing
NIH SBIR/STTR (PI on Phase I and Phase II awards totaling more than $1.7M), NIAAA Clinical Research Program, ARPA-H, BARDA, DARPA, Army Research Office. Specific aims, innovation, approach, milestones, commercialization plans, and biosketch preparation in NIH SF424 format.
IP Portfolio & Freedom-to-Operate
Patent prosecution from invention disclosure through claim charts, PCT national-phase entries (US, EP, China, India), continuation and CIP strategy, FTO analysis against Abbott FreeStyle Libre, Dexcom, Biolinq, SCRAM Systems, Trividia, and other competitors. Coordination with patent counsel.
What I am working on right now.
Continuing development of CMT's noninvasive transdermal biosensor platform for blood analyte monitoring, including the wearable alcohol-detection program with McLean Hospital and Harvard Medical School; the broader multi-analyte clasp product targeting glucose, lactate, and additional biomarkers; ISO 13485 certification and QMS implementation; and federal grant pipelines spanning NIH, NIAAA, ARPA-H, and BARDA. Active research collaborations include Dr. Nathan Shapiro at Beth Israel Deaconess Medical Center / Harvard, Dr. Sergey Piletsky at the University of Leicester, and Dr. Bill Jackson at Base Pair Biotechnologies. Manufacturing and engineering partners include Phillips-Medisize, Voler Systems, Anritsu, and Tozaro. IP portfolio management is coordinated with Marbury Law Group.
Available for retained and project-based consulting.
Typical engagements include due-diligence reviews for investors and acquirers; expert review of grant proposals or peer-reviewed manuscripts; design-of-experiment guidance for biosensor calibration and validation studies; semiconductor process or thin-film failure analysis; patent claim construction and validity opinions; and serving on technical advisory boards for early-stage medical-device and semiconductor companies.